Journal of Molecular and Pharmaceutical Sciences
Volume 4, Numéro 2, Pages 84-97
2025-12-25
Next-generation Anticancer Agents From The Amaryllidaceae Family: Design, Optimization, And Nano-delivery Strategies For Clinical Translation
Authors : Bechlem Houria . Bougandoura Amina Darine . Bahi Meriem . Benouchenne Djamila .
Abstract
The Amaryllidaceae Alkaloids (AAs) represent a structurally rich and mechanistically versatile class of natural products with notable anticancer potential, yet their clinical translation has been hindered by synthetic complexity, narrow chemical space, and persistent pharmacokinetic liabilities. This review provides an integrated, mechanism-focused framework that consolidates recent breakthroughs in biosynthesis, chemical diversification, and targeted pharmacology to redefine the translational landscape of AA-derived therapeutics. We establish a coherent chemical-mechanistic map of AAs diversity, linking underexplored stereo electronic motifs to multimodal mechanisms of action, including ribosomal interference, cytoskeletal disruption, mitochondrial dysfunction, redox imbalance, and emerging immunomodulatory signatures. We highlight transformative medicinal-chemistry innovations, including toxicometabolomics-guided optimization, conformational tuning, and the conceptual foundation for Amaryllidaceae alkaloid inspired proteolysis-targeting chimeras (PROTACs) that collectively expand achievable potency, selectivity, and therapeutic index. A central contribution is the consolidation of advanced nano-engineered delivery platforms (stimuli-responsive, biomimetic, and targeted nanocarriers) designed to overcome fundamental barriers in solubility, stability, and tissue penetration. We critically evaluate current preclinical validation practices, proposing essential experimental and model refinements required for advancing AA candidates toward first in-human testing. Finally, we emphasize the convergence of disruptive technologies, AI-driven generative design, CRISPR-enabled synthetic biology for scalable production, and protein-level modulation strategies. These innovations position the AAs chemical space as a compelling blueprint for next-generation, mechanism-informed anticancer agents, providing a realistic path toward unlocking the long-underutilized therapeutic potential of these distinguished natural products.
Keywords
Amaryllidaceae alkaloids ; Anticancer drug design ; Structure–activity relationship (SAR) ; Nano-delivery systems ; Clinical translation
Les articles similaires
بوسالم أحلام
.
عابد يوسف
.
ص 117-132.
Yahia Zeghoudi
.
pages 74-88.
Said Houari Amel
.
pages 257-268.
El Mezouar Chahrazed
.
Djelti Farah
.
Dali-sahi Majda
.
Bourak Ikram
.
Benguella-benmansour Meriem
.
Berrahoui Samira
.
Kachakouch Youcef
.
Dib Joanna
.
Harek Yahia
.
Dennouni Medjati Nouria
.
pages 444-451.
Matmour Derouicha
.
pages 71-73.
